Stock News•1 months ago
4 Rare Disease Drugmakers With Strong Long-Term Growth Prospects
ALNY, BMRN, RARE and BBIO offer rare-disease growth potential through strong products, pipeline catalysts and high unmet medical needs.
MarketLens
Are Amicus Therapeutics (FOLD) and Autoliv (ALV) Overlooked Opportunities
6 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Amicus Therapeutics: A Rare Disease Gem Acquired
7 months ago
Category
You may also like
Stock News•1 months ago
5 Broker-Loved Stocks to Watch as September Rate Hike Seems Unlikely
Broker-favored stocks including Avnet, RXO, Forward Air, Air Canada, and AMN Healthcare are in focus after weak July jobs data dims September rate-hike odds, potentially supporting valuations if rates...
Stock News•2 months ago
Autoliv, Inc. (ALV) Reports Next Week: Wall Street Expects Earnings Growth
Autoliv (ALV) reports earnings next week. Wall Street expects growth, but the company lacks the key ingredients for a likely earnings beat per current analysis.
Breaking News
View All →Featured Articles
Top Headlines
Stock News•1 hour ago
Microsoft (MSFT) Exceeds Market Returns: Some Facts to Consider
Stock News•1 hour ago
Nvidia (NVDA) Outperforms Broader Market: What You Need to Know
Stock News•1 hour ago
Tesla (TSLA) Laps the Stock Market: Here's Why
Stock News•1 hour ago
If you'd bought $10,000 worth of Amazon stock 10 years ago, here's how much you'd have today
Stock News•1 hour ago